Related Experiment Video
Updated: May 11, 2026
08:21
Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
The intriguing future of pharmacoepidemiology
1Karolinska Institutet, Centre for Pharmacoepidemiology, Department of Medicine, Clinical Epidemiology Unit T2, Karolinska University Hospital, SE-171 76 Stockholm, Sweden. bjorn.wettermark@ki.se
European Journal of Clinical Pharmacology
|May 4, 2013
Summary
Pharmacoepidemiology is a rapidly advancing field driven by increasing drug data. Future research will focus on hospital drugs, patient access, and environmental impacts, while navigating data privacy concerns.
Area of Science:
- Clinical Pharmacology
- Public Health
Background:
- The exponential growth of prescription drug databases has fueled the expansion of pharmacoepidemiology.
- This field has evolved rapidly, positioning itself as a dynamic area within clinical pharmacology.
Purpose of the Study:
- To highlight the continued importance and future directions of pharmacoepidemiology.
- To address the evolving landscape of drug data, research methodologies, and emerging challenges.
Main Methods:
- Review of trends and advancements in pharmacoepidemiology.
- Discussion of the role of observational studies in assessing medication value.
- Exploration of future research needs, including specialist drugs and patient access.
Main Results:
- Pharmacoepidemiology is recognized as a leading and challenging research area.
- Increasing data availability necessitates continued growth in observational studies for medication assessment.
- Future studies must encompass hospital-based drugs and address barriers to effective medicine delivery.
Conclusions:
- Pharmacoepidemiology will remain a dynamic field due to ongoing data expansion and demand for medication value assessment.
- Emerging areas for pharmacoepidemiological research include specialist drugs, patient access, and the environmental impact of medicines.
- Balancing data accessibility with privacy concerns is crucial for the continued development of pharmacoepidemiology.
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:26Introduction to Epidemiology
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...